Skip to main content
Equibles

US BANCORP \DE\

Bank

Position in CRDF — Cardiff Oncology, Inc.

CIK 36104 MINNEAPOLIS, MN
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$4,041
-$995 QoQ
Shares Held
3,109
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 104 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $83,094,208 across 214 Biotechnology names. CRDF ranks #155 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AXSM
Axsome Therapeutics, Inc.
 66,580 $16,296,786
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 32,020 $15,905,293
3 TECH
BIO-TECHNE Corp
 137,966 $9,747,297
4 REGN
Regeneron Pharmaceuticals, Inc.
 5,330 $3,323,466
5 ARGX
Argenx SE
 3,495 $3,242,555
6 ARWR
Arrowhead Pharmaceuticals, Inc.
 38,226 $3,115,799
7 JAZZ
Jazz Pharmaceuticals plc
 10,103 $2,434,518
8 GMAB
Genmab A/S
 88,420 $2,428,896

All Filings in CRDF

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,041 3,109
2026-03-31 $5,036 3,109
2025-12-31 $8,736 3,109
2025-09-30 $6,404 3,109
2025-06-30 $9,793 3,109
2025-03-31 $9,762 3,109
2024-12-31 $13,493 3,109
2024-09-30 $8,301 3,109
2024-06-30 $241 109
2024-03-31 $582 109
2023-12-31 $161 109
2023-09-30 $151 109
2023-06-30 $160 109
2023-03-31 $179 109
2022-12-31 $152 109
2022-09-30 $167 109
2022-06-30 $239 109
2022-03-31 $270 109
2021-12-31 $655 109
2021-09-30 $725 109
2021-06-30 $1,037 156
2021-03-31 $1,009 109